Iwata, Nakao

Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study. [electronic resource] - CNS drugs 01 2020 - 103-116 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1179-1934

10.1007/s40263-019-00692-6 doi


Administration, Cutaneous
Adult
Aged, 80 and over
Asian People
Female
Humans
Male
Middle Aged
Piperazines--adverse effects
Piperidines--adverse effects
Schizophrenia--drug therapy
Transdermal Patch--adverse effects
Treatment Outcome